Li Xiaojing, Wang Yuetong, Gao Yuan, Li Lei, Guo Xin, Liu Dan, Jing Yongkui, Zhao Linxiang
Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang-110016, China.
Org Biomol Chem. 2014 Sep 14;12(34):6706-16. doi: 10.1039/c4ob00703d.
Fourteen of the methyl 2-cyano-3,12-dioxo-18β-olean-1,9(11)-dien-30-oate (CDODO-Me-12, 10d) analogues with different structures of ring C were synthesized to determine the active groups for inhibiting cell growth and inducing apoptosis in human leukemia HL-60 cells. An unsaturated group in ring C was required to maintain the ability to inhibit cell growth and induce apoptosis. Compound 10e with 9(11),12-dien in ring C displayed comparable apoptosis induction ability to 10d associated with decreased levels of c-FLIP, but not Mcl-1 and XIAP. Compound 10e had decreased ability to deplete GSH compared to compound 10d. Compound 10e represents a new active compound acting through a different mechanism from that of compound 10d.
合成了14种具有不同C环结构的2-氰基-3,12-二氧代-18β-齐墩果-1,9(11)-二烯-30-酸甲酯(CDODO-Me-12, 10d)类似物,以确定抑制人白血病HL-60细胞生长和诱导其凋亡的活性基团。C环中的不饱和基团是维持抑制细胞生长和诱导凋亡能力所必需的。C环中具有9(11),12-二烯的化合物10e显示出与10d相当的凋亡诱导能力,同时c-FLIP水平降低,但Mcl-1和XIAP水平未降低。与化合物10d相比,化合物10e消耗谷胱甘肽(GSH)的能力降低。化合物10e代表一种通过与化合物10d不同的机制起作用的新型活性化合物。